Peru’s government on Sunday declared that a fourth wave of COVID-19 infections had begun to hit the country, which has one of the highest mortality rates […]
Medicare could waste up to $605 million per year on the controversial Alzheimer’s drug aducanumab if it is eventually approved for widespread use because it is […]